Neurogenic

Neurogenic Overview

Neurogenic is a clinical-stage diagnostics company developing sensitive immunoassays to assist in the diagnosis of mental disorders. The company has established long-term collaborations with the Weizmann Institute of Science, Rehovot, the Department of Psychiatry, Faculty of Medicine, Tel Aviv University, Tel Aviv, the Beer Yaakov-Ness-Ziona Mental Health Center, Ness Ziona, the Geha Mental Health Center, Petach Tikva, and the Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Beilinson Campus, Rabin Medical Center, Petah Tikva, Israel to develop a straightforward, sensitive ELISA-based immunoassay to detect the autoimmune Platelet-Associated Antibodies (PAA) in the sera of adolescent and pediatric patients suffering from early-onset symptoms of schizophrenia. Neurogenic is now in the final stages of assay optimization. The company is continuing clinical field testing and validation of the assay.

Latest News

Mar 11, 2019 · www.synabs.be

growth-positive

Neurogenic and SYnAbs deal for schizophrenia detection

Neurogenic Ltd., a clinical-stage diagnostics company, has praised its working relationship with SYnAbs, a company that specializes in creating innovative monoclonal antibodies. SYnAbs has generated a unique monoclonal antibody for Neurogenic using a multi-species immunization approach. This antibody is the first of its kind against a confidential peptide discovered and patented by the Weizmann Institute of Science. Neurogenic has been working with SYnAbs to overcome logistical challenges between their respective countries.

Partners

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Ahad Ha'Am St 9, Tel Aviv-Yafo, Israel

Photos & Videos

No files yet

Neurogenic Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info